Mareschal et al. (2016)
Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes | Tier 3 genes |
|---|---|---|---|
| DLBCL | 1 | 0 | 0 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 1
New Tier 1, DLBCL Tier 1, 1
This study, New Tier 2, 0
New Tier 2, DLBCL Tier 2, 0
This study, New Tier 3, 0
New Tier 3, DLBCL Tier 3, 0
All other DLBCL studies, DLBCL Tier 1, 124
All other DLBCL studies, DLBCL Tier 2, 210
All other DLBCL studies, DLBCL Tier 3, 387
Novel genes reported in this study
Tier 1
| New gene | DLBCL tier |
|---|---|
| XPO1 | 1 |
Details
Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe
Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et
al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients
Expands the Repertoire of Somatic Mutations in Diffuse Large B-cell Lymphoma.” Genes, Chromosomes
& Cancer 55 (3): 251–67. https://doi.org/10.1002/gcc.22328.